Close

Oppenheimer Starts KERX, CLDX, PSTI, IMMU at Outperform, ONCY at Perform

May 17, 2011 9:22 AM EDT
Get Alerts KERX Hot Sheet
Price: $3.36 --0%

Rating Summary:
    6 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 7 | New: 42
Join SI Premium – FREE
Oppenheimer's Boris Peaker initiated coverage on a number of Biotech stocks Tuesday morning:
  • KERYX Biopharma (Nasdaq: KERX) with an Outperform rating and a $7 price target
  • Celldex (Nasdaq: CLDX) with an Outperform rating and a $6 price target
  • Pluristem Therapeutics (Nasdaq: PSTI) with an Outperform rating and a $5 price target
  • Immunomedics (Nasdaq: IMMU) with an Outperform rating and a $6 price target
  • Oncolytics (Nasdaq: ONCY) with a Perform rating
Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage